AEON Biopharma, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

AEON Biopharma, Inc. reported Cash And Cash Equivalents At Carrying Value of $3.01 million for the year ending 2025.

  • AEON Biopharma, Inc. showed an increase of +23,023.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from AEON Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2021 to 2025), AEON Biopharma, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 504.3%.
  • Historical annual values: Fiscal year 2025: $3.01 million | Fiscal year 2024: $13.0 thousand | Fiscal year 2023: $5.16 million | Fiscal year 2023: $31.20 million | Fiscal year 2022: $9.75 million | Fiscal year 2021: $497.4 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: